πŸ‡ΊπŸ‡Έ FDA
Patent

US 9777024

Heteroaryl inhibitors of PDE4

granted A61KA61K31/435A61K31/44

Quick answer

US patent 9777024 (Heteroaryl inhibitors of PDE4) held by Tetra Discovery Partners expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tetra Discovery Partners
Grant date
Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K31/435, A61K31/44, A61K31/4418, A61K31/496